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II. SCOPE, PLANNING, AND INITIAL STEPS§
The Middletown Project was undertaken as a combined trial and demon-
stration of how the Sabin oral poliovirus vaccine could be given on a
city-wide, simultaneous or mass basis in an urban American community of
approximately 30,000 population. Specific objectives were multiple. They
included: the assessment of the immunological effectiveness of this
immunizing agent when given in such a setting; a determination of the
degree of public acceptance of the vaccine; a delineation of the respective
roles in a community vaccination campaign of a research group such as the
Yale University Poliomyelitis Study Unit, the City Health officer, and
thepracticingphysicians; and ananalysis ofthe actual problems or mechanics
of vaccine administration.
This was an ambitious project for a research group of the size of the
Yale Poliomyelitis Study Unit, and, as mentioned in the preceding paper,
it was far and away the largest vaccine trial as yet attempted by this group.
Without the participation of graduate students from the Department of
Epidemiology and Public Health (Yale University) and of many more
members of the faculty than had been recruited for such studies before,
and without the vigorous participation of the Middletown Department of
Health and its director, a study of this magnitude could never have been
* Instructor in Public Health.
**Epidemic Intelligence Service Officer, U. S. Public Health Service, assigned to
Yale Poliomyelitis Study Unit, 1 January-15 June 1961.
*** Director of Health, Middletown, Connecticut.
tAnna M. R. Lauder Professor of Epidemiology and Public Health.
t Professor Emeritus of Epidemiology and Preventive Medicine.
¶[ Professor of Epidemiology and Pediatrics.
§ Aided by a grant from The National Foundation.
Received for publication 17 November 1961.
447YALE JOURNAL OF BIOLOGY AND MEDICINEV
accomplished. Indeed one might question the advisability of a university
research group initiating a project calling for mass vaccination of an
urban population on such a scale. A university group is better equipped
to carry out small and detailed trials in which exacting studies are made,
such as, for instance, the trial involving approximately 200 New Haven
families which this Study Unit completed in early 1960.1 However, in
1961-1962, during the early stages of official licensing of the oral polio-
virus vaccine, there is also a need for more precise information and
knowledge regarding the community-wide use of this new form of vaccine
and, in view of our previous experience, the present project has proved to
be a suitable one for our Study Group.
To engage in a city-wide trial in an urban population of 30,000 or
more is a task which calls for a considerable degree of planning. The
extent to which state or municipal departments of health are able to
devote time, personnel, and other facilities for such an undertaking must
be decided well in advance; the time, interest, and support which the
practicing physicians can afford to give deserves careful thought and
discussion in the local medical societies. For this reason we have gone into
some detail in describing how this project, sponsored jointly by a university
and by a municipal health department, has been implemented.
It will be unfortunate indeed if when the use of oral poliovirus vaccine
becomes official in the United States, advantage is not taken of the oppor-
tunity to explore new approaches in order to achieve more complete
coverage of the population than has been the case with the Salk-type
vaccine.2 The nature of the oral vaccine which allows ingestion to replace
injection makes it ideally suited to rapid and painless administration to
large segments of the population. In planning the Middletown project, a
major aim was to achieve at least an 85 per cent level of immunization in
both the school-age population and in the preschool children between three
months and five years of age. A special effort was made to cover the
hard-to-reach groups, particularly those of low socio-economic levels.
MIDDLETOWN, CONNECTICUT
The city and its people. The city of Middletown (of which illustrations
are shown in Figs. 1 and 2, and a map in Fig. 3) is a small New England
city, incorporated in 1651. It is located in central Connecticut on the
Connecticut River. Actually, it is a township containing a thickly populated
urban center and surrounding suburban and rural communities covering
a total area of 45 square miles. This city was chosen for the vaccine trial
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because of its convenient size and its excellent health department, and
because it is a more or less circumscribed community conveniently close to
New Haven (26 miles).
According to the 1960 census, Middletown has a total population of
30,237, exclusive of the student body of Wesleyan University which
numbers about 1,000 students, and exclusive of the inmates of several
state institutions. The population consists of approximately 83 per cent
native born, 15 per cent foreign born, and 2 per cent non-white. Of the
native-born group approximately 30 per cent are of Italian and 15 per
cent of Polish extraction. It is a semi-industrial community as well as a
university town. There are several fair-sized industries as well as one
large plant (United Aircraft). The area possesses an excellent small hospital
(Middlesex Memorial Hospital) centrally located in the city.
Publc health officials and municipal institutions. Middletown has an
active Health Department under a full-time Director of Health, with a staff
of one nurse, one full-time and one part-time secretary, and a full-time
sanitarian. The Health Department has excellent relationships with the local
physicians, its director having been a general practitioner in the city
from 1946-1956.
Nurses for the public schools are employed by the Board of Education,
which proved to be a more important local agency in our program than
we had at first anticipated. Three nurses cover the eleven elementary
schools, one junior high school, and two high schools. The nurse for
the three parochial schools is supplied by the Health Department. There
is also a District Nurse Association (D.N.A.), incorporated and endowed;
it has its own building, in which a well-child conference is held once
every two weeks. There is considerable cooperation between the D.N.A.
and the Department of Health.
One evening newspaper is published daily, the Middletown Press. The
Hartford Courant, a morning newspaper, has a wide circulation because
it contains a page with news of Middletown. Radio Station WCNX is
located in Middletown, and television stations located in New Haven and
Hartford are received exceptionally well.
Past history of poliomyelitis in Middletoum. The city has in the past
been the site of sizeable epidemics of poliomyelitis, notably an extensive
one in 1930. During the past few years cases of poliomyelitis have been
reduced to a minimum. The record has been as follows:
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Number of
Year poliomyelitis cases
1954 5
1955 4
1956 0
1957 0
1958 0
1959 0
1960 0*
1961 0
OBJECTIVES OF THE MIDDLETOWN ORAL POLIOVIRUS VACCINE PROJECT
These were well outlined in advance and required little modification as
the trial progressed. In essence the objectives were:
i. To determine what per cent of the designated age groups of the popu-
lation could be reached with oral vaccine offered in sequential doses to all
children aged 3 months to 18 years in the urban, suburban, and semi-rural
area of Middletown, Connecticut.
ii. To conduct studies on factors influencing acceptance or rejection
of oral vaccine by different socio-economic groups. This would include
a retrospective assay of attitudes towards the Salk-type vaccine.
iii. To make special efforts to reach the preschool group, utilizing
all available local mechanisms for determining its size in advance, so
that as wide a coverage as possible of children of this most susceptible
age could be achieved.
iv. To assay the attitudes of the local medical profession toward the
program and the degree to which physicians were willing to participate.
v. To collect information with regard to the existence of possible contra-
indications to the oral vaccine:
(a) By following the birth records for a nine-month period
after initiation of the vaccination program to see whether any
alteration occurred in the number of still-births and malformations
as compared with previous years.
(b) By following the tonsillectomy operations which were per-
* In 1960 there was a case reported in the adjacent small town of Portland.
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formed during and shortly after the administration of vaccine to
see if there were any untoward effects.
(c) By observing any immediate clinical reactions which might
occur in the vaccinees and continuing close surveillance of the popu-
lation during the months of February through June 1961. (This
would include clinical observations and laboratory tests on all
Middletown patients admitted during this period to the Middlesex
Hospital with evidence of infection of the central nervous system.)
FIG. 3. Schematic map of Middletown indicating industrial and densely populated
residential areas.
vi. To conduct pre-vaccinal and post-vaccinal serological studies in
order to determine the immunizing capacity of the oral vaccine, given in two
sequential doses, six weeks apart, to this particular population.*
*An original plan to administer the vaccine in three separate doses of monovalent
vaccine was changed to a program in which the vaccine was given in two doses:
a first dose of monovalent type I vaccine, and six weeks later a second dose of
bivalent vaccine, types II and III. The decision to adopt the new schedule was based
largely on the successful result with this regimen obtained by our Study Unit in the
New Haven City oral poliovirus vaccine trial carried out in 1960 among preschool
children.'
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vii. To conduct virological surveys prior to, during, and after the trial.
These studies were to be aimed in part toward the determination of
prevalence of enteroviruses which might act as interfering agents, and in
part toward determining the persistence of the attenuated polioviruses in
the community. Sampling of the sewage on a weekly basis before and after
the trial and periodic collection of rectal swabs from young children attend-
ing the well-child clinic were the survey methods chosen for this purpose.
ORGANIZATION OF THE PROJECT
Participating and approving agencies. As stated earlier, the program was
carried out under the joint direction of the Poliomyelitis Study Unit and
others of the Department of Epidemiology and Public Health, Yale Uni-
versity School of Medicine and the Middletown Department of Health.*
To provide day to day direction of the project and liaison between these
groups, a special team was formed. Two of the members (J. R. C. Pearson
and D. G. Miller of the Yale staff) devoted full time to the study for a
period of five months. In addition, a series of technical committees was
appointed to assume responsibility for individual objectives outlined above.
Some 50 persons participated in the project for varying periods on a part-
time basis.
Prior to initiating plans for the program, approval was obtained from
Dr. Franklin M. Foote, Commissioner of Health, State of Connecticut;
the Public Health Committee of the Connecticut State Medical Society;
the Middletown Board of Health; the Central Medical Association of
Middletown; and the Middlesex County Medical Association.
Participation of the local medical profession. One reason for the choice
of the city of Middletown was the existence there of a group of physicians
who had expressed interest in having the project carried out in their city.
This interest was subsequently reflected in the favorable attitude of the
local medical societies and their respective votes of approval.
During the planning stage, meetings with various medical groups were
held. It was the opinion of the physicians that the administration of the
* The Communicable Disease Center of the Public Health Service kindly furnished
us with a consultant (Dr. R. E. Serfling) to aid with the problem of sampling this
population. This agency also assigned Dr. David Miller of its Epidemiological Intelli-
gence Service to the project; he participated actively in an executive capacity, during
a 6-month period (Jan.-June 1961). Assistance was also given by Dr. Mila Rindge of
the Bureau of Preventable Diseases, Connecticut State Department of Health.
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vaccination program should be the responsibility of the health officer and
project directors. They favored the setting up of clinics in schools or other
appropriate locations where the vaccine could be given under medical
supervision, both to school and preschool children.* It was agreed that the
name of the private physician would be written on the permission slip, and
subsequently, information as to the actual date on which the first and
second doses of vaccine were received would be recorded and sent to the
child's physician after the vaccination program had been completed.
Finally, when the immunization results in terms of antibody responses were
available, these would also be sent to the physicians concerned.
As a major premise from the beginning, it was assumed that the
oral vaccine would begiven under medicalsuperzision. This was interpreted
to mean that at each clinic, set up for mass administration of the vaccine
on a certain series of days, a physician would be in attendance while the
vaccine was being given by the public health nurses. A number of
Middletown physicians volunteered to render this service. Physician mem-
bers of the Yale team conducting the antibody survey and physicians from
the Connecticut State Department of Health also participated in this
supervisory medical activity.
SUMMARY
In connection with the Oral Poliovirus Vaccine Project carried out in
Middletown, Connecticut early in 1961, efforts were made to explore new
approaches to the problem of reaching at least 85-90 per cent of the children
in this semi-industrial city of 30,000 populaton. To attain this goal, many
different groups, agencies, and individuals participated, including members
of the Department of Epidemiology and Public Health, Yale University,
and the Middletown Department of Health which assumed joint responsi-
bility for the undertaking. In Middletown, the private physicians, the
District Nurse Association, and several volunteer groups also took part.
The planning for the project included provision for a survey to determine
factors affecting acceptance of Salk-type and oral vaccine; clinical sur-
veillance after oral vaccine administration to determine the effectiveness of
the two dose schedule in a community-wide program; and a virological
survey to measure the persistence of vaccine viruses in the community and
* Early in the planning stage several general practitioners and pediatricians stated
that they did not wish to have the vaccine given in their private offices because of the
crowded conditions which might ensue there. They indicated a preference for assisting
the program in other ways.
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their impact on the prevalence of other enteroviruses. Early in the planning
phase the project was presented to various state and local organized
medical groups, and approved and endorsed by them, and by the Com-
missioner of Health of Connecticut.
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